CVS Health Corporation (CVS) Institutional Ownership & Insider Trading

2,059 institutions reported holding CVS Health Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 8 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CVSCVS Health CorporationFollow CVS — free

Healthcare Plans · Healthcare

—

Price chart with a free account

Market cap: 119.5B
P/E TTM: 24.6
Dividend yield: 2.8%
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

2,059 institutions held 89.2% of the shares. Across filers that reported both quarters, shares held changed +1.4%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	2,059	1140	+1.4%	641	257	630	79
Mar 26	1,845	1099	-1.1%	592	98	626	150
Dec 25	1,891	1128	-1.8%	573	121	622	86
Sep 25	1,790	1127	+4.3%	542	153	595	70
Jun 25	1,725	1093	+0.7%	525	120	630	122
Mar 25	1,709	1062	+3.4%	466	220	661	128
Dec 24	1,609	1044	+1.1%	322	77	858	329
Sep 24	1,786	1000	-3.8%	411	99	895	173

CVS Health Corporation — questions

Who owns CVS Health Corporation stock?: 2,059 institutions reported CVS Health Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (9.6%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%), Capital World Investors (5.9%).
Are CVS Health Corporation insiders buying or selling?: 8 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from CVS Health Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.